0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CDMO for Transdermal Patches and Oral Film Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22P16637
Home | Market Reports | Health| Medical Devices & Equipment
Global CDMO for Transdermal Patches and Oral Film Market Research Report 2024
BUY CHAPTERS

Global CDMO for Transdermal Patches and Oral Film Market Research Report 2025

Code: QYRE-Auto-22P16637
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CDMO for Transdermal Patches and Oral Film Market

The global market for CDMO for Transdermal Patches and Oral Film was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.
The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.
This report aims to provide a comprehensive presentation of the global market for CDMO for Transdermal Patches and Oral Film, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CDMO for Transdermal Patches and Oral Film.
The CDMO for Transdermal Patches and Oral Film market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CDMO for Transdermal Patches and Oral Film market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CDMO for Transdermal Patches and Oral Film companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CDMO for Transdermal Patches and Oral Film Market Report

Report Metric Details
Report Name CDMO for Transdermal Patches and Oral Film Market
Segment by Type
  • Transdermal Patches
  • Oral Film
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AdhexPharma, Nissha, Tapemark, tesa, LTS Lohmann, IntelGenx, MedPharm, Adhesives Research, Shilpa Medicare Limited, ROFARMA, Kindeva Drug Delivery, ProSolus, Altergon, Youwei Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CDMO for Transdermal Patches and Oral Film company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CDMO for Transdermal Patches and Oral Film Market report?

Ans: The main players in the CDMO for Transdermal Patches and Oral Film Market are AdhexPharma, Nissha, Tapemark, tesa, LTS Lohmann, IntelGenx, MedPharm, Adhesives Research, Shilpa Medicare Limited, ROFARMA, Kindeva Drug Delivery, ProSolus, Altergon, Youwei Biotech

What are the Application segmentation covered in the CDMO for Transdermal Patches and Oral Film Market report?

Ans: The Applications covered in the CDMO for Transdermal Patches and Oral Film Market report are Pharmaceutical Company, Biotechnology Company, Generic Company

What are the Type segmentation covered in the CDMO for Transdermal Patches and Oral Film Market report?

Ans: The Types covered in the CDMO for Transdermal Patches and Oral Film Market report are Transdermal Patches, Oral Film

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transdermal Patches
1.2.3 Oral Film
1.3 Market by Application
1.3.1 Global CDMO for Transdermal Patches and Oral Film Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CDMO for Transdermal Patches and Oral Film Market Perspective (2020-2031)
2.2 Global CDMO for Transdermal Patches and Oral Film Growth Trends by Region
2.2.1 Global CDMO for Transdermal Patches and Oral Film Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CDMO for Transdermal Patches and Oral Film Historic Market Size by Region (2020-2025)
2.2.3 CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Region (2026-2031)
2.3 CDMO for Transdermal Patches and Oral Film Market Dynamics
2.3.1 CDMO for Transdermal Patches and Oral Film Industry Trends
2.3.2 CDMO for Transdermal Patches and Oral Film Market Drivers
2.3.3 CDMO for Transdermal Patches and Oral Film Market Challenges
2.3.4 CDMO for Transdermal Patches and Oral Film Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CDMO for Transdermal Patches and Oral Film Players by Revenue
3.1.1 Global Top CDMO for Transdermal Patches and Oral Film Players by Revenue (2020-2025)
3.1.2 Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Players (2020-2025)
3.2 Global CDMO for Transdermal Patches and Oral Film Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CDMO for Transdermal Patches and Oral Film Revenue
3.4 Global CDMO for Transdermal Patches and Oral Film Market Concentration Ratio
3.4.1 Global CDMO for Transdermal Patches and Oral Film Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CDMO for Transdermal Patches and Oral Film Revenue in 2024
3.5 Global Key Players of CDMO for Transdermal Patches and Oral Film Head office and Area Served
3.6 Global Key Players of CDMO for Transdermal Patches and Oral Film, Product and Application
3.7 Global Key Players of CDMO for Transdermal Patches and Oral Film, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CDMO for Transdermal Patches and Oral Film Breakdown Data by Type
4.1 Global CDMO for Transdermal Patches and Oral Film Historic Market Size by Type (2020-2025)
4.2 Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Type (2026-2031)
5 CDMO for Transdermal Patches and Oral Film Breakdown Data by Application
5.1 Global CDMO for Transdermal Patches and Oral Film Historic Market Size by Application (2020-2025)
5.2 Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CDMO for Transdermal Patches and Oral Film Market Size (2020-2031)
6.2 North America CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025)
6.4 North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CDMO for Transdermal Patches and Oral Film Market Size (2020-2031)
7.2 Europe CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025)
7.4 Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size (2020-2031)
8.2 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2020-2025)
8.4 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CDMO for Transdermal Patches and Oral Film Market Size (2020-2031)
9.2 Latin America CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025)
9.4 Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size (2020-2031)
10.2 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025)
10.4 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdhexPharma
11.1.1 AdhexPharma Company Details
11.1.2 AdhexPharma Business Overview
11.1.3 AdhexPharma CDMO for Transdermal Patches and Oral Film Introduction
11.1.4 AdhexPharma Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.1.5 AdhexPharma Recent Development
11.2 Nissha
11.2.1 Nissha Company Details
11.2.2 Nissha Business Overview
11.2.3 Nissha CDMO for Transdermal Patches and Oral Film Introduction
11.2.4 Nissha Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.2.5 Nissha Recent Development
11.3 Tapemark
11.3.1 Tapemark Company Details
11.3.2 Tapemark Business Overview
11.3.3 Tapemark CDMO for Transdermal Patches and Oral Film Introduction
11.3.4 Tapemark Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.3.5 Tapemark Recent Development
11.4 tesa
11.4.1 tesa Company Details
11.4.2 tesa Business Overview
11.4.3 tesa CDMO for Transdermal Patches and Oral Film Introduction
11.4.4 tesa Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.4.5 tesa Recent Development
11.5 LTS Lohmann
11.5.1 LTS Lohmann Company Details
11.5.2 LTS Lohmann Business Overview
11.5.3 LTS Lohmann CDMO for Transdermal Patches and Oral Film Introduction
11.5.4 LTS Lohmann Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.5.5 LTS Lohmann Recent Development
11.6 IntelGenx
11.6.1 IntelGenx Company Details
11.6.2 IntelGenx Business Overview
11.6.3 IntelGenx CDMO for Transdermal Patches and Oral Film Introduction
11.6.4 IntelGenx Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.6.5 IntelGenx Recent Development
11.7 MedPharm
11.7.1 MedPharm Company Details
11.7.2 MedPharm Business Overview
11.7.3 MedPharm CDMO for Transdermal Patches and Oral Film Introduction
11.7.4 MedPharm Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.7.5 MedPharm Recent Development
11.8 Adhesives Research
11.8.1 Adhesives Research Company Details
11.8.2 Adhesives Research Business Overview
11.8.3 Adhesives Research CDMO for Transdermal Patches and Oral Film Introduction
11.8.4 Adhesives Research Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.8.5 Adhesives Research Recent Development
11.9 Shilpa Medicare Limited
11.9.1 Shilpa Medicare Limited Company Details
11.9.2 Shilpa Medicare Limited Business Overview
11.9.3 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Introduction
11.9.4 Shilpa Medicare Limited Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.9.5 Shilpa Medicare Limited Recent Development
11.10 ROFARMA
11.10.1 ROFARMA Company Details
11.10.2 ROFARMA Business Overview
11.10.3 ROFARMA CDMO for Transdermal Patches and Oral Film Introduction
11.10.4 ROFARMA Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.10.5 ROFARMA Recent Development
11.11 Kindeva Drug Delivery
11.11.1 Kindeva Drug Delivery Company Details
11.11.2 Kindeva Drug Delivery Business Overview
11.11.3 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Introduction
11.11.4 Kindeva Drug Delivery Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.11.5 Kindeva Drug Delivery Recent Development
11.12 ProSolus
11.12.1 ProSolus Company Details
11.12.2 ProSolus Business Overview
11.12.3 ProSolus CDMO for Transdermal Patches and Oral Film Introduction
11.12.4 ProSolus Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.12.5 ProSolus Recent Development
11.13 Altergon
11.13.1 Altergon Company Details
11.13.2 Altergon Business Overview
11.13.3 Altergon CDMO for Transdermal Patches and Oral Film Introduction
11.13.4 Altergon Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.13.5 Altergon Recent Development
11.14 Youwei Biotech
11.14.1 Youwei Biotech Company Details
11.14.2 Youwei Biotech Business Overview
11.14.3 Youwei Biotech CDMO for Transdermal Patches and Oral Film Introduction
11.14.4 Youwei Biotech Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
11.14.5 Youwei Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Transdermal Patches
 Table 3. Key Players of Oral Film
 Table 4. Global CDMO for Transdermal Patches and Oral Film Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global CDMO for Transdermal Patches and Oral Film Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CDMO for Transdermal Patches and Oral Film Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global CDMO for Transdermal Patches and Oral Film Market Share by Region (2020-2025)
 Table 8. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global CDMO for Transdermal Patches and Oral Film Market Share by Region (2026-2031)
 Table 10. CDMO for Transdermal Patches and Oral Film Market Trends
 Table 11. CDMO for Transdermal Patches and Oral Film Market Drivers
 Table 12. CDMO for Transdermal Patches and Oral Film Market Challenges
 Table 13. CDMO for Transdermal Patches and Oral Film Market Restraints
 Table 14. Global CDMO for Transdermal Patches and Oral Film Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global CDMO for Transdermal Patches and Oral Film Market Share by Players (2020-2025)
 Table 16. Global Top CDMO for Transdermal Patches and Oral Film Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CDMO for Transdermal Patches and Oral Film as of 2024)
 Table 17. Ranking of Global Top CDMO for Transdermal Patches and Oral Film Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by CDMO for Transdermal Patches and Oral Film Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of CDMO for Transdermal Patches and Oral Film, Headquarters and Area Served
 Table 20. Global Key Players of CDMO for Transdermal Patches and Oral Film, Product and Application
 Table 21. Global Key Players of CDMO for Transdermal Patches and Oral Film, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global CDMO for Transdermal Patches and Oral Film Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Type (2020-2025)
 Table 25. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Type (2026-2031)
 Table 27. Global CDMO for Transdermal Patches and Oral Film Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Application (2020-2025)
 Table 29. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Application (2026-2031)
 Table 31. North America CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AdhexPharma Company Details
 Table 47. AdhexPharma Business Overview
 Table 48. AdhexPharma CDMO for Transdermal Patches and Oral Film Product
 Table 49. AdhexPharma Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 50. AdhexPharma Recent Development
 Table 51. Nissha Company Details
 Table 52. Nissha Business Overview
 Table 53. Nissha CDMO for Transdermal Patches and Oral Film Product
 Table 54. Nissha Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 55. Nissha Recent Development
 Table 56. Tapemark Company Details
 Table 57. Tapemark Business Overview
 Table 58. Tapemark CDMO for Transdermal Patches and Oral Film Product
 Table 59. Tapemark Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 60. Tapemark Recent Development
 Table 61. tesa Company Details
 Table 62. tesa Business Overview
 Table 63. tesa CDMO for Transdermal Patches and Oral Film Product
 Table 64. tesa Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 65. tesa Recent Development
 Table 66. LTS Lohmann Company Details
 Table 67. LTS Lohmann Business Overview
 Table 68. LTS Lohmann CDMO for Transdermal Patches and Oral Film Product
 Table 69. LTS Lohmann Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 70. LTS Lohmann Recent Development
 Table 71. IntelGenx Company Details
 Table 72. IntelGenx Business Overview
 Table 73. IntelGenx CDMO for Transdermal Patches and Oral Film Product
 Table 74. IntelGenx Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 75. IntelGenx Recent Development
 Table 76. MedPharm Company Details
 Table 77. MedPharm Business Overview
 Table 78. MedPharm CDMO for Transdermal Patches and Oral Film Product
 Table 79. MedPharm Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 80. MedPharm Recent Development
 Table 81. Adhesives Research Company Details
 Table 82. Adhesives Research Business Overview
 Table 83. Adhesives Research CDMO for Transdermal Patches and Oral Film Product
 Table 84. Adhesives Research Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 85. Adhesives Research Recent Development
 Table 86. Shilpa Medicare Limited Company Details
 Table 87. Shilpa Medicare Limited Business Overview
 Table 88. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product
 Table 89. Shilpa Medicare Limited Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 90. Shilpa Medicare Limited Recent Development
 Table 91. ROFARMA Company Details
 Table 92. ROFARMA Business Overview
 Table 93. ROFARMA CDMO for Transdermal Patches and Oral Film Product
 Table 94. ROFARMA Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 95. ROFARMA Recent Development
 Table 96. Kindeva Drug Delivery Company Details
 Table 97. Kindeva Drug Delivery Business Overview
 Table 98. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product
 Table 99. Kindeva Drug Delivery Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 100. Kindeva Drug Delivery Recent Development
 Table 101. ProSolus Company Details
 Table 102. ProSolus Business Overview
 Table 103. ProSolus CDMO for Transdermal Patches and Oral Film Product
 Table 104. ProSolus Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 105. ProSolus Recent Development
 Table 106. Altergon Company Details
 Table 107. Altergon Business Overview
 Table 108. Altergon CDMO for Transdermal Patches and Oral Film Product
 Table 109. Altergon Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 110. Altergon Recent Development
 Table 111. Youwei Biotech Company Details
 Table 112. Youwei Biotech Business Overview
 Table 113. Youwei Biotech CDMO for Transdermal Patches and Oral Film Product
 Table 114. Youwei Biotech Revenue in CDMO for Transdermal Patches and Oral Film Business (2020-2025) & (US$ Million)
 Table 115. Youwei Biotech Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. CDMO for Transdermal Patches and Oral Film Picture
 Figure 2. Global CDMO for Transdermal Patches and Oral Film Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CDMO for Transdermal Patches and Oral Film Market Share by Type: 2024 VS 2031
 Figure 4. Transdermal Patches Features
 Figure 5. Oral Film Features
 Figure 6. Global CDMO for Transdermal Patches and Oral Film Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global CDMO for Transdermal Patches and Oral Film Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Company Case Studies
 Figure 9. Biotechnology Company Case Studies
 Figure 10. Generic Company Case Studies
 Figure 11. CDMO for Transdermal Patches and Oral Film Report Years Considered
 Figure 12. Global CDMO for Transdermal Patches and Oral Film Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global CDMO for Transdermal Patches and Oral Film Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global CDMO for Transdermal Patches and Oral Film Market Share by Region: 2024 VS 2031
 Figure 15. Global CDMO for Transdermal Patches and Oral Film Market Share by Players in 2024
 Figure 16. Global Top CDMO for Transdermal Patches and Oral Film Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CDMO for Transdermal Patches and Oral Film as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by CDMO for Transdermal Patches and Oral Film Revenue in 2024
 Figure 18. North America CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America CDMO for Transdermal Patches and Oral Film Market Share by Country (2020-2031)
 Figure 20. United States CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe CDMO for Transdermal Patches and Oral Film Market Share by Country (2020-2031)
 Figure 24. Germany CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Share by Region (2020-2031)
 Figure 32. China CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America CDMO for Transdermal Patches and Oral Film Market Share by Country (2020-2031)
 Figure 40. Mexico CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Share by Country (2020-2031)
 Figure 44. Turkey CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AdhexPharma Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 48. Nissha Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 49. Tapemark Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 50. tesa Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 51. LTS Lohmann Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 52. IntelGenx Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 53. MedPharm Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 54. Adhesives Research Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 55. Shilpa Medicare Limited Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 56. ROFARMA Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 57. Kindeva Drug Delivery Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 58. ProSolus Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 59. Altergon Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 60. Youwei Biotech Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart